AMERICAN EXCEPTIONALISM ACQ CORP. A
AEXA
10.85
0.00
-0.02%
AMERICAN EXCEPTIONALISM ACQ CORP. A
US · AEXA
#3705 by market cap
Listed 2025
10.85
0.00
-0.02%
Live - 5344 symbols - heartbeat 206s ago
· 2026-10-08 09:48
After-hours
10.85
0.00%
- Market cap
- 536.56M
- P/E (TTM)i
- 0.00
- P/Bi
- 1.61
- EPSi
- 0.00
- Div yieldi
- 0.00%
- 52W posi
- 24%
Reader sentiment
Are you bullish or bearish on AEXA?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Mixed / stable
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 61.52%
- Institutions
- 84
- As of
- 2026/Q3 vs. prior period
Holder types
Hedge Fund40.08%
Individual/Insider30.85%
Mutual Fund8.81%
Public Company5.77%
Government Pension Fund4.45%
Private Company2.24%
Family Office/Trust0.17%
Other7.62%
Top holders as of 2026-03-30
Chamath Palihapitiya
29.64% · 14.66M sh
ExodusPoint Capital Management, LP
3.33% · 1.65M sh
The Goldman Sachs Group, Inc.
2.92% · 1.44M sh
Moore Capital Management, LP
2.43% · 1.20M sh
D. E. Shaw & Co., L.P.
2.43% · 1.20M sh
MYDA Advisors LLC
2.38% · 1.18M sh
Healthcare of Ontario Pension Plan Trust Fund
2.22% · 1.10M sh
Empyrean Capital Partners, LP
2.22% · 1.10M sh
Magnetar Capital Partners, LP
2.22% · 1.10M sh
Alberta Investment Management Corporation
2.22% · 1.10M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
6 filings tracked · 1 buys · 0 sells
| Name | Role | Stake |
|---|---|---|
| Chamath Palihapitiya | Chairperson | 29.64% |
| Jas Athwal | Independent Director | 0.30% |
| Michael Teng | Independent Director | 0.30% |
| Kevin Conroy | -- | 0.30% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-31 | Michael Teng | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2025-09-28 | Chamath Palihapitiya | Chairperson | Private Acquisition | +175,000 | $10.00 |
| 2025-09-24 | Kevin Conroy | -- | Initial Statement of Beneficial | 0 | -- |
| 2025-09-24 | Chamath Palihapitiya | Chairperson | Initial Statement of Beneficial | 0 | -- |
| 2025-09-24 | Jas Athwal | Independent Director | Initial Statement of Beneficial | 0 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 09:48:06 · For reference only, not investment advice and not tailored to your situation.